Cyclizine dihydrochloride

Research use only, not for human use.

Cyclizine Dihydrochloride is a histamine H1 antagonist. It is given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness.

Cyclizine Dihydrochloride is a histamine H1 antagonist. It is given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness.

Cyclizine (100 μM) dihydrochloride significantly inhibits nitrite accumulation and iNOS protein levels in the LPS-stimulated in RAW 264.7 cells supernatants.Cyclizine dihydrochloride inhibits anti-IgE-induced histamine release from isolated human lung fragments, with an IC50 of 5.42 μM.

Cyclizine (1, 10 mg/kg) dihydrochloride enhances locomotor activity of mice in a dose-dependent manner. Animal Model:Naive male CDI mice (Charles River) weighing 25-30 g Dosage:1, 10 mg/kg Administration:s.c.; locomotor activity (crossings) measured every 15 min for 2 hr.Result:Enhanced locomotor activity in a dose-dependent manner.

——

Others

Other Targets

H1 receptor

——

——

5897-18-7

339.3

C18H24Cl2N2

>98% (HPLC)

——

CN1CCN(CC1)C(c1ccccc1)c1ccccc1.Cl.Cl

——

(-20℃)

With Ice Pack

≥ 2 years